Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-01-28

Clinical Trial Update: Study to Evaluate the Efficacy of Lithium Carbonate in Spinal Cord Injury Patients With Neuropathic Pain [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating lithium carbonate for neuropathic pain in spinal cord injury patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lithium carbonate (Lithium carbonate)

Snippet

Sponsor: China Spinal Cord Injury Network | Conditions: Neuropathic Pain, Neuralgia | Phase 2 | Status: COMPLETED